CD38 Ligand-Drug Conjugates For Targeted Cancer Therapy

• 收藏
• 分享

专利权人:

发明人:

Youli Zu

申请号：

US15565666

公开号：

US20180078649A1

申请日:

2016.04.08

申请国别(地区):

US

年份:

2018

代理人:

摘要：

Disclosed are compositions and methods relating to nucleic acid aptamers that specifically target CD38 protein and also selective binding to CD38-expressing cells. The ligand-drug conjugates specifically target CD38-expressing cancer cells and subsequently internalize into the cell.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/